Cerus Corporation (CERS)
After hours:
| Previous Close | 1.6300 |
| Open | 1.6400 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 1.6200 - 1.7400 |
| 52 Week Range | 1.2500 - 2.5900 |
| Volume | |
| Avg. Volume | 1,175,842 |
| Market Cap | 309.446M |
| Beta (5Y Monthly) | 1.18 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.1300 |
| Earnings Date | Oct 30, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.90 |
Business WireCerus Corporation Announces Workshop and Abstracts at the 2024 AABB Annual Meeting
CONCORD, Calif., October 18, 2024--Cerus Corporation (Nasdaq: CERS) today announced a selection of abstracts to be presented at the 2024 Association for the Advancement of Blood & Biotherapies (AABB) Annual Meeting, taking place in Houston, Texas from October 19 through October 22. This year’s AABB Annual Meeting attracts individuals and institutions from around the globe involved in the fields of transfusion medicine and biotherapies.
Business WireCerus Corporation to Release Third Quarter 2024 Financial Results on October 30, 2024
CONCORD, Calif., October 18, 2024--Cerus Corporation (Nasdaq: CERS) announced today that its third quarter 2024 financial results will be released on Wednesday, October 30, 2024, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will discuss the Company’s financial results and provide a general business overview and outlook.
